| Immune checkpoint inhibitors in advanced non–small cell lung cancer HI Assi, AO Kamphorst, NM Moukalled, SS Ramalingam Cancer 124 (2), 248-261, 2018 | 122 | 2018 |
| Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment F Kreidieh, I Abou Dalle, N Moukalled, J El-Cheikh, E Brissot, M Mohty, ... International Journal of Hematology 116 (3), 330-340, 2022 | 48 | 2022 |
| Deferasirox: over a decade of experience in thalassemia NM Moukalled, R Bou-Fakhredin, AT Taher Mediterranean Journal of Hematology and Infectious Diseases 10 (1), 2018 | 37 | 2018 |
| Iron overload in patients with myelodysplastic syndromes: an updated overview NM Moukalled, FA El Rassi, SN Temraz, AT Taher Cancer 124 (20), 3979-3989, 2018 | 31 | 2018 |
| Impact of adding antithymocyte globulin to posttransplantation cyclophosphamide in haploidentical stem-cell transplantation J El-Cheikh, R Devillier, R Dulery, R Massoud, F Al Chami, N Ghaoui, ... Clinical Lymphoma Myeloma and Leukemia 20 (9), 617-623, 2020 | 30 | 2020 |
| Association between radiotherapy and risk of cancer associated venous thromboembolism: a sub-analysis of the COMPASS—CAT study S Temraz, N Moukalled, GT Gerotziafas, I Elalamy, L Jara-Palomares, ... Cancers 13 (5), 1033, 2021 | 21 | 2021 |
| Reduced intensity is preferred over myeloablative conditioning allogeneic HCT in chronic lymphocytic leukemia whenever indicated: a systematic review/meta-analysis MA Kharfan-Dabaja, N Moukalled, T Reljic, J El-Asmar, A Kumar Hematology/oncology and stem cell therapy 11 (2), 53-64, 2018 | 21 | 2018 |
| Feasibility of the combination of venetoclax and asparaginase-based chemotherapy for adult patients with relapsed/refractory acute lymphoblastic leukemia J El-Cheikh, NM Moukalled, H El Darsa, R Massoud, SS Kanj, R Mahfouz, ... Clinical Lymphoma Myeloma and Leukemia 18 (10), e441-e444, 2018 | 20 | 2018 |
| What is the role of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia? NM Moukalled, MA Kharfan-Dabaja Bone marrow transplantation 55 (2), 325-331, 2020 | 16 | 2020 |
| Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation NM Moukalled, H El Darsa, Y Haibe, R Massoud, SS Kanj, R Mahfouz, ... Bone Marrow Transplantation 54 (4), 620-624, 2019 | 16 | 2019 |
| Venetoclax: a new partner in the novel treatment era for acute myeloid leukemia and myelodysplastic syndrome J El-Cheikh, G Bidaoui, M Saleh, N Moukalled, I Abou Dalle, ... Clinical Hematology International 5 (2), 143-154, 2023 | 15 | 2023 |
| Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies J El-Cheikh, N Moukalled, F Malard, A Bazarbachi, M Mohty Blood Cancer Journal 13 (1), 83, 2023 | 15 | 2023 |
| Outcomes of patients with malignancy admitted to the intensive care units: a prospective study HI Assi, NA Halim, I Alameh, J Khoury, V Nahra, F Sukhon, ... Critical Care Research and Practice 2021 (1), 4792309, 2021 | 14 | 2021 |
| Bi-and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives I Abou Dalle, R Dulery, N Moukalled, L Ricard, N Stocker, J El-Cheikh, ... Blood Cancer Journal 14 (1), 23, 2024 | 8 | 2024 |
| The use of intrathecal chemotherapy and dexamethasone for secondary prevention of blinatumomab-related neurotoxicity. A Aqel, O Fakhreddine, A Atoui, N Moukalled, J El Cheikh, A Bazarbachi, ... Current Research in Translational Medicine 69 (2), 103285-103285, 2021 | 8 | 2021 |
| Recurrent Campylobacter bacteremia as the first manifestation of hypogammaglobulinemia: A case report and literature review AA Gharamti, N Moukalled, A Taher, ZA Kanafani Infection & Chemotherapy 52 (3), 415, 2019 | 8 | 2019 |
| Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment S Karam, M Haidous, I Abou Dalle, A Dendooven, N Moukalled, ... Critical reviews in oncology/hematology 183, 103926, 2023 | 7 | 2023 |
| Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study A Bazarbachi, M Labopin, N Moukalled, N Kröger, C Rautenberg, ... Clinical Cancer Research 30 (9), 1778-1787, 2024 | 6 | 2024 |
| Azacitidine in combination with venetoclax maintenance post-allogeneic hematopoietic stem cell transplantation in t cell acute lymphoblastic leukemia MA Hassan, N Moukalled, J El Cheikh, A Bazarbachi, I Abou Dalle Clinical Hematology International 5 (1), 52-55, 2023 | 6 | 2023 |
| Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care NM Moukalled, R Bou Fakhredin, AT Taher Expert Review of Hematology 15 (12), 1055-1061, 2022 | 6 | 2022 |
